Identification of alpha(1)-antitrypsin variants in plasma with the use of proteomic technology.
about
Glycomic Characterization of Induced Pluripotent Stem Cells Derived from a Patient Suffering from Phosphomannomutase 2 Congenital Disorder of Glycosylation (PMM2-CDG)Active trafficking of alpha 1 antitrypsin across the lung endotheliumA missense mutation in the bovine SLC35A3 gene, encoding a UDP-N-acetylglucosamine transporter, causes complex vertebral malformation.Targeted biomarker discovery by high throughput glycosylation profiling of human plasma alpha1-antitrypsin and immunoglobulin A.A novel glycosylphosphatidylinositol-anchored glycoside hydrolase from Ustilago esculenta functions in β-1,3-glucan degradationGlobal serum glycoform profiling for the investigation of dystroglycanopathies & Congenital Disorders of Glycosylation.Human plasma protein N-glycosylationChanges in total plasma and serum N-glycome composition and patient-controlled analgesia after major abdominal surgery.Probing serpin conformational change using mass spectrometry and related methods.Effects of glycosylation on the stability and flexibility of a metastable protein: the human serpin α(1)-antitrypsin.
P2860
Q27311626-04038F29-4F79-4455-9C51-63E463981F86Q27343637-A94481BA-81B6-4B3F-BAD9-54B36516CC9FQ34475345-A720BC1D-507A-4FC1-83BD-2B4884373010Q34988803-F00AAF9E-7ACB-429C-A327-A01FF055D18BQ36120179-AB95256F-466D-4C9C-BEFD-2BA44459415EQ36806841-73552B0F-4187-4AA6-916F-51FBB35F9CDCQ36963945-CC794C3B-F085-497C-8CCA-D77D9A0B5F33Q37159904-E729A9F1-CAA0-417D-8944-1F0AC98FE537Q37955396-11AEDE7D-C5A0-4454-A909-91F77D3ED6B9Q42797410-D50E7716-5DBB-4861-AF2A-4E17EF47BD7A
P2860
Identification of alpha(1)-antitrypsin variants in plasma with the use of proteomic technology.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Identification of alpha(1)-ant ...... e use of proteomic technology.
@ast
Identification of alpha(1)-ant ...... e use of proteomic technology.
@en
type
label
Identification of alpha(1)-ant ...... e use of proteomic technology.
@ast
Identification of alpha(1)-ant ...... e use of proteomic technology.
@en
prefLabel
Identification of alpha(1)-ant ...... e use of proteomic technology.
@ast
Identification of alpha(1)-ant ...... e use of proteomic technology.
@en
P2093
P1433
P1476
Identification of alpha(1)-ant ...... e use of proteomic technology.
@en
P2093
Clayton PT
Johnson AW
Whitehouse DB
Winchester BG
P304
P407
P577
2001-11-01T00:00:00Z